▲ Peaking
Business
All eyes on data on Biogen’s tau therapy
Biogen's experimental anti-tau therapy shows promise in slowing cognitive decline for early Alzheimer's patients.
Diranersen
1 trends tracked about this subject — the full history, oldest to newest below.